Gardasil Firestorm In Denmark and HPV Vaccines: Updates From Central And South America
JUNE 21, 2015 By Norma Erickson
In March 2015, a Danish national television station (TV2) aired a documentary focusing on girls who suspected they had been injured by the HPV vaccine Gardasil. Immediately after the airing of the show, girls with similar experiences started coming out of the woodwork. Virtually all of the girls had the same story to tell.
They began to have serious new medical conditions shortly after using Gardasil so they would go to the doctor. According to Luise Juellund, the vast majority of doctors would tell them the HPV vaccine has no serious side effects and offer psychological problems as an alternative reason for the new symptoms.
Luise should know, her daughter is one of the seriously injured and cannot be left home alone because of daily seizures and hour-long periods of unconsciousness. After disclosing the new symptoms she was experiencing after Gardasil, she was referred for psychological evaluation. Psychiatrists cleared her and she has now been diagnosed with POTS (postural orthostatic tachycardia syndrome) a suspected side effect of HPV vaccines.
According to Peter la Cour, Head of the Center for Functional Disorders in Copenhagen, the practice of refusing girls the opportunity for medical examination and treatment on the grounds that psychological problems can cause similar symptoms is terrible. He states:
The handful of girls I’ve seen has not been mentally ill, but very physically sick and disabled. We simply cannot have sick people rejected under the assumption that they are mentally ill. None of us know anything about why they are so sick. Alleged knowledge of psychological reasons is scandalous character assassination of the young women.
Serious Adverse Reactions Reach One In 500
Denmark is divided into five healthcare regions. On June 1, the government established a single point of entrance in each one of these regions to accept and examine anyone suspected of having a negative reaction to Gardasil. The response was overwhelming.
The influx of girls seeking care was 60% higher than expected, suggesting the harmful effects was greater than Danish health authorities had foreseen. By June 9th, the waiting list to be evaluated was at least six to nine months long. (See map below.) Two of the five centers did not know how long the girls would have to wait.
Jesper Mehlsen from Synkopecenteret at Frederiksberg Hospital is one of the specialists who takes care of the girls. He stated:
We thought it (the serious adverse event rate) was about one in 10,000 people who had side effects. Now it turns out that there are at least two per 10 000. Suddenly it was doubled.
Unfortunately, the avalanche of girls seeking medical diagnoses and treatment after their HPV vaccinations continued to increase.
Only two days later, on June 11th, Dr. Jesper Mehlsen had to revise his estimate of the number of injured girls stating:
A realistic estimate is that one in 500 girls – or 1,000 of the 500,000 vaccinated experience serious side effects.
Dr. Mehlsen helped to research the HPV vaccine and personally vaccinated 3,000 girls. Now, he operates the regional intake center in Frederiksberg and will be in charge of coordinating work across the country. He noted that as of June 11th, 360 girls had been referred for study.
Dr. Stig Gerdes fears this is only the tip of the iceberg. He stated:
It will not it surprise me if we end up reaching several thousand who have been sick. I even stopped administering Gardasil a few years ago, after vaccinating about 100 patients.
More than a handful of them became ill after the vaccine. Several of them very, very seriously and completely devastated.
Is HPV Vaccine Safety Based On Mere Guesswork?
Danish Health Minister, Nick Haekkerup, and the National Board of Health continue to defend the use of the HPV vaccine Gardasil despite the more than 600 young girls suspected of becoming seriously ill from the vaccine.
Both still claim the vaccine is safe and the benefits outweigh the risks.
Experts who are working with the injured girls disagree. Coordinator of the Danish Society of Obstetrics and Gynecology’s national guidelines for HPV vaccination, Gynecologist Jeppe Schroll states:
We can simply not say because we do not know. There is so much uncertainty in the studies that were made on the vaccine – so it is a pure guess. It may well be that they (the health authorities) are right, but it could just as well be the opposite.
His opinion is reinforced by Dr. Diane Harper, who helped develop Gardasil for Merck and stated:
There is no data to substantiate that the benefits outweigh the risks. The truth is that we know very little about the side effects of the HPV vaccine.
Dr. Schroll suggests that Merck’s own analysis of possible serious side effects is based on a questionnaire which clinical trial participants completed two weeks after the vaccine was given.
In the years since, women are asked whether they have received ’new medical conditions.’
According to Dr. Schroll, this provides a high degree of uncertainty. Some may get sick during the first 14 days, but women who become ill later may not connect it to the vaccine.
Dr. Schroll stated another source of error is that in the last major Danish/Swedish study among a million girls only looked at those with a diagnosis; not necessarily those with a list of symptoms such as debilitating paralysis of the arms and legs, pain, chronic fatigue, sudden daily fainting, daily migraines and dizziness – like the more than 600 Danish girls currently referred for evaluation.
According to Dr. Jeppe Schroll:
I think the reason why they have not found the side effects in the studies is that they have not been looking for them.
Experts Weigh In On HPV Vaccination Policy
Danish GP’s believe one should examine the many sick girls who are suspected to have had adverse reactions to Gardasil before even considering implementing Gardasil 9.
Deputy Chairman of the PLO and member of the Board of Health’s vaccination committee, Niels Urich Holm agrees, stating:
We know too little about the side effects. We fear first, that it (Gardasil 9) might have more side effects than the current one (Gardasil), which has greater side effects than other vaccines. And secondly, we believe that it would be prudent to await the investigations currently going on in all regions to find out about the disease and symptoms we have seen in a number of girls, maybe caused by the vaccine. Therefore, one should wait to introduce the new HPV vaccine, which is being approved for use in Denmark until the five new regional HPV centers have studied the sick girls who received the current vaccine properly.
SF (Socialist People’s Party) spokesperson Ozlem Cekic also backed up the GP’s request that the cautionary principle be applied when she stated:
I do not understand why the National Board of Health is so eager to launch a new HPV vaccine. I think overall that the Agency has behaved foolishly in this case, where they have been too slow to react. We can see that many girls may have become ill by severe side effects. It shall be fully investigated.
She also stated that the Socialist People’s Party will take HPV vaccine issues up politically after the election and shall require deeper insight into the documentation underlying the vaccine.
Health Rapporteur Liselott Blixt of the Danish People’s Party was one of the people who led the effort to get the HPV vaccine Gardasil introduced in Denmark in 2008. She now wants it abolished. She states:
The fact that we have so many, perhaps up to 5,000 young women who suddenly become so sick must have the consequence that we simply stop the vaccine. I was the first who said a big ‘yes’ to it, but now I will also be the first to abolish it, because we politicians must take responsibility for ensuring that we have adopted it. Not least in light of the fact that we do not actually have any treatment options to offer the most sick.
Let’s hope the authorities in Denmark follow expert advice and make sure that young women’s health is no longer sacrificed for the promise of a benefit fifteen to twenty years from now.
No healthy young woman should have to sacrifice her health to see if a cancer prevention experiment will work!
JUNE 13, 2015 By Norma Erickson
Are HPV vaccines the number one cause of coincidence around the globe?
Are we facing one of the worst epidemics of mass hysteria the world has ever seen? Apparently, health authorities around the world would like us to believe one of these two scenarios.
Almost without exception, survivors of new medical conditions after the administration of Gardasil or Cervarix are told their problems are coincidental, psychosomatic, mass hysteria, conversion disorder, and so on…ad nauseam. The health authorities in one country (Colombia) even went so far as to attribute new medical conditions after Gardasil to the overuse of Ouija boards.
If all of the above fail, the next step is to try and blame the new symptoms on the parents with phrases like Munchausen by proxy, factitious disorder, fabricated or induced illness, attention seeking, simply out for money, and so on.
The first problem with all of these theories is they are usually put forth after little or no medical investigation. This leaves parents who believed their health authorities and had their daughters injected with the newest miracle vaccine feeling confused, abandoned and betrayed by the very people they trusted to protect their children’s health and well-being.
The second problem with all of these theories is they delay potentially life-saving treatments which could be provided if investigations took place, accurate diagnoses made and treatment protocols designed and implemented.
Read the following updates and ask yourself – What is wrong with this picture?
Colombia: First Reported Fatality After Gardasil
On May 22, 2015 16-year old Karen Durán-Cantor died after complications related to new onset autoimmune disorders believed to have been triggered by two injections of Gardasil, the human papillomavirus vaccine currently being given to school age girls throughout the country.
Karen received her first Gardasil shot at the end of 2013 and the second one a few months later in early 2014. According to her mother, Karen’s hands got swollen almost immediately.
She began to experience joint and finger pain that was diagnosed as Juvenile Rheumatoid Arthritis. Despite receiving medical therapy, her disease progressed forcing Karen to stop attending school due to the constant severe pain. Consequently, she was not able to graduate from high school with her classmates.
Karen and her family sought a second opinion in Bogotá’s Clinica Colsubsidio where she was also diagnosed with pleural effusion requiring drainage to help her breathe. By this time, Karen had lost the ability to walk. She could not go to the bathroom or take a shower by herself. She had nearly constant pain on the right side of her body (the side where the Gardasil injection was administered). Karen frequently complained she was short of breath and it was difficult for her to breathe.
Just prior to her death, Karen experienced difficulty breathing and required oxygen. She was referred to La Samaritana Hospital in Bogotá where she was admitted to the Intensive Care Unit where she developed fatal respiratory failure.
These are photos of Karen before and after her Gardasil injections. Please note this dramatic change occured between the end of 2013 and the middle of 2015 – approximately a year-and-a-half.
Despite her personal pain, Karen produced a video to warn others about the possible consequences of using Gardasil shortly before her death.
This is the first documented death after the development of autoimmune disorders following the administration of Gardasil in Colombia.
In addition to the pain and grief this family has already had to endure, they have a long journey ahead of them as they attempt to locate a forensic expert to determine the exact cause of their daughter’s death.
Karen’s family is not alone in Colombia. Hundreds of girls have developed new medical conditions that may have been triggered by Colombia’s recent mandatory HPV vaccination program. The Colombian National Institute of Health did carry out an investigation. The lead investigator was Dr. Fernando De La Hoz, a prominent epidemiologist, who resigned after concluding that the adverse events developed by the girls was a result of mass psychogenic disease.
What is wrong with this picture?
Mexico: Several schools cancel HPV vaccinations
Gardasil was introduced in Mexico in 2008, but only to 125 targeted municipalities with the ”lowest human development index” which were estimated to have the highest incidence of cervical cancer. The quadrivalent HPV vaccine was delivered to these communities via mobile health clinics to girls who were 12-16 years of age using the currently recommended dosing schedule of 0, 2, and 6-months.
In 2009, the program was expanded to include 182 municipalities, still with the ”lowest human development index,” but this time with the first two doses being delivered at 0 and 6 months and the third dose 60 months later (5 years) and the targeted girls being ages 9-12.
Considering the current Supreme Court Case in India, one has to wonder… Were these parents informed of the fact their daughters were participants in a clinical trial to determine appropriate dosing regimens?
Why did both programs target girls in so many locations with the lowest human development index? What was the rate of adverse events among the participants?
In 2011, Mexico’s National Immunization Council approved a nationwide expansion of its HPV vaccination program to include school-based HPV vaccination for all 9-year-old girls.
Two months before leaving office in 2012, Mexican President Felipe Calderon made HPV vaccination mandatory for all 11-12 year old girls.
According to Chapter 4 of the Comprehensive Cervical Cancer Control: A guide to essential practice, published on February 11, 2013 by the World Health organization, Mexico is currently using alternative dosing schedule, which is not approved or recommended by WHO at this time. (verify on page 6)
May 2015, after only 500 doses of Gardasil were administered under this program, the Mexican Social Security Institute (IMSS) had to cancel the HPV immunization program at some schools because parents were refusing to allow their 9-year-old girls to receive the injections.
What Is Wrong With This Picture?
Brazil: Uptake Of HPV Vaccine Drops From 83% To 40%
In 2012, Gardasil sales in Japan generated $140 million. In 2013, the Japanese Health Ministry rescinded its recommendation for the use of HPV vaccines causing Merck to look for replacement markets.
By August of the same year, Brazil had agreed to set aside almost $160 million for the purchase of HPV vaccines for use in 2014.
But, 2014 would not be Brazilian girl’s first exposure to Gardasil. According to an article published in Elselvier’s Trials in Vaccinology in 2013, clinical trials using Gardasil were being conducted in the municipality of Campos dos Goytacazes, Rio de Janeiro, Brazil during 2010, 2011 and 2012.
According to the abstract, the objectives of these trials were:
Assess vaccination coverage in that municipality after adopting several strategies for active search and missed opportunities for vaccination against HPV. Evaluate acceptance for the vaccine and reasons for refusal the HPV vaccine. Evaluate the frequency and occurrence of adverse events to that vaccine. A survey of reduction of genital warts was also conducted.
The paper goes on to state that between September 2010 and December 2012, approximately 90,000 doses of Gardasil were used. This number of doses should have covered 30,000 recipients.
However, the ’evaluation of the frequency and occurrence of adverse events’ consisted of conducting a survey of 1,000 randomly selected teenagers to be followed up on 96 hours after vaccine administration to evaluate safety and tolerability.
The authors stated the results of this survey as follows:
There were observed a total of 430 local and systemic events in 360 subjects (36% of 1000 girls), stratified by each dose received. No serious adverse events or any hospitalization were reported;
96 hours; only four days? Are these people serious? How can the safety and tolerability of any vaccine be accurately assessed only 4 days after administration?
Nevertheless, the authors’ conclusion confidently stated:
According to our results, it seems evident that the good coverage achieved by vaccination against HPV in Campos dos Goytacazes, coupled with no serious adverse events to the vaccine reported throughout the study, point to the feasibility of this vaccination strategy, which can also be used in other municipalities. Taking into account not only the benefits but also the results with regard to the reduction of genital warts, amply demonstrated by international studies  and , we then seek to suggest the inclusion of HPV vaccination in the Brazilian calendar.
By the end of the same year this study was published, Brazilian health authorities had committed nearly $160 million precious healthcare dollars to the purchase of Gardasil for their 2014 national immunization program.
Between March and May of 2014, 83% of the targeted girls (ages 11-13) in Brazil had received their Gardasil injections. By the end of the year 100% of the targeted 4.9 million girls had been vaccinated.
During the same period (March through May) this year another 4.9 million girls (ages 9-11) were targeted, but only 40.2% of them took the vaccine. Could it be because of stories like these?
What Is Wrong With This Picture?
Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil